Fedro Peccatori
www.mendeley.com
0000-0001-8227-8740
178 papers found
Refreshing results…
Inhibition of cfu-gm growth by idarubicinol containing plasma samples obtained from poor prognosis lymphoma patients treated with 3-days infusion idarubicin
Epirubicin and docetaxel is a very effective regimen for peripheral blood progenitor cells (PBPC) mobilization
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)
Usefulness or not of follow-up in breast cancer | Utilité ou inutilité du suivi (follow-up) des patientes avec carcinome du sein, après traitement adjuvant
Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients
Pure ovarian immature teratoma, a unique and curable disease: 10 years’ experience of 32 prospectively treated patients
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease — A 6-year update
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy
Quantization of CD34+ Peripheral Blood Hematopoietic Progenitors for Autografting in Cancer Patients
Primary Ovarian Small Cell Carcinoma: Four More Cases
Anti-tumor and immunomodulatory activity of intraperitoneal IFN-γ in ovarian carcinoma patients with minimal residual tumor after chemotherapy
Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease
Intraperitoneal Recombinant γ-Interferon in Patients with Recurrent Ascitic Ovarian Carcinoma: Modulation of Cytotoxicity and Cytokine Production in Tumor-associated Effectors and of Major Histocompatibility Antigen Expression on Tumor Cells
Killing of Tumor Cells with Pleiotropic Drug Resistance by OK432-Activated Effector Cells
Lymphocytes infiltrating ovarian carcinoma: Modulation of functional activity by intraperitoneal treatment with biological response modifiers
T-cell receptor gene rearrangements and expression in normal human large granular lymphocytes (LGL) and their pathological expansions
Missing publications? Search for publications with a matching author name.